一个代谢物联合交付策略,以改善mRNA脂质纳米粒子交付
Yutian Ma1, Vincent Fung1, Rachel VanKeulen-Miller2
1Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
ACS applied materials & interfaces
|April 24, 2025
概括
在脂质纳米颗粒 (LNP) 中与信使RNA (mRNA) 共同输送代谢物可增强蛋白质表达. 这种策略可以提高mRNA的翻译效率,以获得更好的治疗结果.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 纳米技术纳米技术
背景情况:
- 脂质纳米颗粒 (LNP) 对于mRNA传递至关重要,保护有效载荷并促进细胞进入.
- 最佳的mRNA转化为蛋白质需要足够的细胞代谢物,包括能源,辅酶和氨基酸.
- 由于代谢物稀缺而导致的翻译效率低下可能会限制LNP治疗的疗效,并需要更高的剂量.
研究的目的:
- 开发和验证一种使用mRNA载荷LNP的代谢物联合递送策略.
- 通过提供必要的代谢物来提高mRNA翻译效率和蛋白质表达.
- 为了证明这一策略在各种条件和模型中具有广泛的适用性.
主要方法:
- 通过将必需代谢物与mRNA有效载荷一起纳入水相,形成脂质纳米颗粒 (LNP).
- 在LNP配方过程中保持有机相组件的稳定摩尔比率.
- 通过体外和体内实验验验证该方法,包括在多个细胞系和在小鼠的正常和缺氧条件下进行的研究.
主要成果:
- 代谢物联合递送策略成功增强了mRNA翻译和蛋白质表达.
- 该方法在不同的细胞系和生理条件中显示出广泛的适用性.
- 机制和疗效研究证实了代谢物联合递送对基于LNP的mRNA疗法的益处.
结论:
- 在mRNA LNP中同时输送代谢物是改善蛋白质表达的可通用策略.
- 这种方法可以克服代谢物限制,可能减少剂量要求并改善治疗结果.
- 该战略对推进基于mRNA LNP的研究和治疗应用具有重大前景.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


